デフォルト表紙
市場調査レポート
商品コード
1477385

臨床試験支援サービス市場- 世界の産業規模、動向、機会、予測、サービス別、スポンサー別、地域別、競合別、2019年~2029年

Clinical Trials Support Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Sponsor, By Region and Competition, 2019-2029F

出版日: | 発行: TechSci Research | ページ情報: 英文 187 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

臨床試験支援サービス市場- 世界の産業規模、動向、機会、予測、サービス別、スポンサー別、地域別、競合別、2019年~2029年
出版日: 2024年05月06日
発行: TechSci Research
ページ情報: 英文 187 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の臨床試験支援サービス市場の2023年の市場規模は205億2,000万米ドルで、2029年までの予測期間のCAGRは5.25%で着実な成長が予測されています。

臨床試験は医学研究の中核であり、ヘルスケアの革新と進歩を推進しています。しかし、このような臨床試験を効率的かつ効果的に実施するには、数多くの支援サービスが必要です。世界の臨床試験支援サービス市場は、臨床試験の成功に不可欠な各種サービスを提供することで、臨床試験の円滑な実施を促進する上で極めて重要な役割を果たしています。患者の募集からデータ管理まで、これらのサービスは臨床研究の完全性と妥当性を確保する上で極めて重要です。

市場概要
予測期間 2025-2029
2023年の市場規模 205億2,000万米ドル
2029年の市場規模 279億6,000万米ドル
CAGR 2024-2029 5.25%
急成長セグメント 治験施設管理
最大市場 北米

慢性疾患の増加と革新的な治療法の必要性から、世界中で臨床研究活動が急増し、支援サービスの需要が高まっています。電子データ収集(EDC)、クラウドベースのソリューション、人工知能(AI)などの技術の進歩は、臨床試験業務に革命をもたらし、プロセスを合理化し、効率を高めています。個別化医療や標的療法の出現により、臨床試験はより複雑化し、バイオマーカー分析、遺伝子検査、プロトコールデザインなどの業務に専門的なサポートサービスが必要となっています。規制当局が課す厳しい規制要件により、臨床試験プロセス全体を通じて綿密な文書化、品質保証、コンプライアンスが必要となり、規制当局支援サービスの需要を煽っています。

主な市場促進要因

革新的治療に対する需要の増加

臨床試験の世界化

主な市場課題

患者の募集と維持

物流の複雑さ

主な市場動向

技術の進歩

セグメント別の洞察

サービス別の洞察

地域別の洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 臨床試験支援サービスの世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別(治験施設管理、患者募集管理(患者募集・登録サービス、患者維持、その他)、データ管理、事務スタッフ、IRB、その他)
    • スポンサー別(製薬・バイオ医薬品、医療機器、その他)
    • 企業別(2023年)
    • 地域別
  • 市場マップ

第6章 北米の臨床試験支援サービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • スポンサー別
    • 国別
  • 北米国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の臨床試験支援サービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • スポンサー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の臨床試験支援サービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • スポンサー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の臨床試験支援サービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • スポンサー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの臨床試験支援サービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • スポンサー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収(もしあれば)
  • 製品上市(もしあれば)
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Charles River Laboratories International, Inc.
  • Wuxi Apptec
  • IQVIA Inc.
  • Syneos Health
  • Eurofins Scientific
  • Ppd, Inc.(Thermo Fisher Scientific Inc.)
  • Icon Plc
  • Laboratory Corporation Of America Holdings
  • Parexel International(MA)Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 23961

Global Clinical Trials Support Services Market was valued at USD 20.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. Clinical trials are at the heart of medical research, driving innovation and advancements in healthcare. However, conducting these trials efficiently and effectively requires a multitude of support services. The global clinical trials support services market plays a pivotal role in facilitating the smooth execution of these trials by providing a range of services essential for their success. From patient recruitment to data management, these services are critical in ensuring the integrity and validity of clinical research.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 20.52 Billion
Market Size 2029USD 27.96 Billion
CAGR 2024-20295.25%
Fastest Growing SegmentClinical Trial Site Management
Largest MarketNorth America

The growing prevalence of chronic diseases and the need for innovative treatments have led to a surge in clinical research activities worldwide, driving the demand for support services. Technological advancements, such as electronic data capture (EDC), cloud-based solutions, and artificial intelligence (AI), are revolutionizing clinical trial operations, streamlining processes, and enhancing efficiency. With the emergence of personalized medicine and targeted therapies, clinical trials have become more complex, requiring specialized support services for tasks such as biomarker analysis, genetic testing, and protocol design. Stringent regulatory requirements imposed by regulatory authorities necessitate meticulous documentation, quality assurance, and compliance throughout the clinical trial process, fuelling the demand for regulatory support services.

Key Market Drivers

Increasing Demand for Innovative Therapies

In the fast-paced realm of healthcare, the demand for innovative therapies continues to surge as populations age, chronic diseases proliferate, and expectations for personalized treatments rise. This escalating demand is propelling the global clinical trials support services market to new heights. Clinical trials are the cornerstone of medical research, enabling the evaluation of new drugs, therapies, and medical devices. However, the complexity and regulatory requirements associated with conducting clinical trials necessitate specialized support services. As the quest for groundbreaking treatments intensifies, the importance of efficient and reliable clinical trial support services becomes paramount. Breakthroughs in genomics, molecular biology, and other fields are unveiling novel therapeutic targets and treatment modalities. This has led to a surge in the development of innovative therapies, including gene therapies, immunotherapies, and precision medicines, which require rigorous clinical testing.

The global burden of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is on the rise, creating an urgent need for effective treatments. Clinical trials play a crucial role in evaluating the safety and efficacy of new interventions to address these health challenges. Regulatory bodies worldwide are imposing stringent requirements for the approval of new drugs and medical devices to ensure patient safety and efficacy. Navigating the regulatory landscape necessitates expertise in compliance, documentation, and quality assurance, driving the demand for specialized support services. There is a growing emphasis on patient-centric healthcare, with stakeholders increasingly prioritizing patient engagement and feedback throughout the drug development process. This shift underscores the importance of patient recruitment, retention, and compliance in clinical trials, driving the need for tailored support services.

Pharmaceutical companies and contract research organizations (CROs) are increasingly conducting clinical trials in diverse geographic regions to access diverse patient populations, accelerate recruitment, and navigate regulatory challenges. This globalization trend necessitates comprehensive support services to ensure seamless trial execution across different jurisdictions.

Globalization of Clinical Trials

The global clinical trials support services market encompasses a wide range of services aimed at facilitating the planning, execution, and management of clinical trials. These services include clinical trial design, site selection, patient recruitment, regulatory compliance, data management, and quality assurance, among others. As the complexity and scale of clinical trials have increased, so too has the demand for specialized support services to ensure their successful implementation.

The primary driver of growth in the clinical trials support services market is the increasing globalization of clinical research. Pharmaceutical and biotechnology companies are expanding their reach beyond traditional markets to leverage diverse patient populations, access novel therapies, and navigate complex regulatory environments. This has led to a surge in demand for support services tailored to international trials, including language translation, cultural adaptation, and regulatory consulting. The adoption of advanced technologies such as electronic data capture (EDC), remote monitoring, and wearable devices has transformed the conduct of clinical trials. These technologies offer opportunities to streamline trial processes, enhance data quality, and improve patient engagement. As a result, there is a growing need for support services that can harness the potential of these technologies while ensuring compliance with regulatory standards and data security requirements. Modern clinical trials are becoming increasingly complex, involving multiple study sites, diverse patient populations, and intricate study protocols. Managing such complexity requires specialized expertise in areas such as project management, protocol design, and regulatory affairs. Clinical trials support services providers offer valuable insights and resources to help sponsors navigate these complexities and optimize trial outcomes. There is a growing emphasis on patient-centricity in clinical research, with stakeholders seeking to improve patient recruitment, retention, and engagement. Clinical trials support services play a crucial role in developing patient-centric strategies, including targeted recruitment campaigns, patient education materials, and remote monitoring solutions. By placing the needs and experiences of patients at the forefront, these services contribute to the success and sustainability of clinical trials.

Key Market Challenges

Patient Recruitment and Retention

Recruiting and retaining participants for clinical trials is a perennial challenge, particularly in the context of global trials. Cultural differences, language barriers, and socio-economic factors can influence patient participation rates, making it challenging to achieve the desired sample size within stipulated timelines. Additionally, ensuring diversity and representation among trial participants is crucial for producing generalizable results. Leveraging innovative recruitment strategies, such as digital outreach campaigns and community engagement initiatives, can help overcome these challenges and enhance patient recruitment and retention rates.

Logistical Complexities

Conducting global clinical trials involves intricate logistical arrangements, including sourcing investigational drugs, managing supply chains, and coordinating site operations across multiple geographies. Delays in logistics can disrupt trial timelines and escalate costs, underscoring the importance of robust supply chain management strategies. Furthermore, geopolitical tensions, natural disasters, and public health emergencies can pose unforeseen challenges, necessitating agile contingency planning to mitigate risks and ensure the continuity of clinical trial operations.

Key Market Trends

Technological Advancements

In recent years, the global healthcare landscape has been significantly influenced by technological advancements, leading to the transformation of various sectors within the industry. One such area experiencing a remarkable evolution is the realm of clinical trials support services. As innovation continues to surge, the demand for efficient and streamlined processes in clinical research has intensified, propelling the growth of the global market for clinical trials support services. The digitization of healthcare data has revolutionized the way clinical trials are conducted and managed. Advanced electronic data capture (EDC) systems, cloud-based platforms, and wearable devices have enabled real-time collection, analysis, and sharing of clinical data, enhancing efficiency and accuracy in trial processes. Moreover, technologies such as blockchain are being leveraged to ensure data integrity, transparency, and security throughout the trial lifecycle.

AI and ML technologies are revolutionizing various aspects of clinical trials, from patient recruitment and eligibility screening to predictive analytics and adverse event monitoring. These advanced analytics tools can sift through vast amounts of data to identify patterns, predict outcomes, and optimize trial protocols, ultimately expediting the drug development process and reducing costs.

The adoption of telemedicine platforms and remote monitoring devices has facilitated decentralized clinical trials (DCTs), allowing patients to participate in studies from the comfort of their homes. This approach not only improves patient recruitment and retention but also enhances the diversity and inclusivity of trial populations. Furthermore, remote monitoring tools enable real-time data collection and analysis, leading to more efficient and patient-centric trial management.

VR and AR technologies are increasingly being utilized to enhance patient engagement and compliance in clinical trials. By creating immersive and interactive experiences, these technologies can educate patients about trial procedures, simulate medical interventions, and alleviate anxiety during procedures or treatment. Additionally, VR and AR applications are being employed in training healthcare professionals and researchers, improving their skills and knowledge in clinical trial conduct.

Segmental Insights

Service Insights

Based on the category of service, Clinical Trial Site Management emerged as the dominant player in the global market for Clinical Trials Support Services in 2023 One of the primary drivers of the dominance of clinical trial site management is the need for efficient resource utilization. Sponsors and contract research organizations (CROs) are increasingly looking to streamline operations, reduce costs, and accelerate trial timelines. By outsourcing site management functions to specialized service providers, they can leverage expertise, infrastructure, and technology to optimize trial performance. Moreover, the expansion of clinical research globally has necessitated a more decentralized approach to trial management. With trials being conducted across diverse geographic regions and healthcare settings, effective site management becomes paramount for ensuring consistency, quality, and regulatory compliance across sites.

Regional Insights

North America emerged as the dominant region in the global Clinical Trials Support Services market in 2023, holding the largest market share in terms of value. North America boasts a sophisticated healthcare infrastructure comprising state-of-the-art research facilities, academic institutions, and specialized hospitals. This infrastructure provides the necessary framework for conducting clinical trials across various therapeutic areas. The region is at the forefront of technological innovation, with significant investments in healthcare IT, data analytics, and artificial intelligence. These technological advancements have revolutionized the conduct of clinical trials, enabling efficient data collection, analysis, and management.

Key Market Players

Charles River Laboratories International, Inc.

Wuxi Apptec

IQVIA Inc

Syneos Health

Eurofins Scientific

Ppd, Inc (Thermo Fisher Scientific Inc.)

ICON plc

Laboratory Corporation Of America Holdings

Parexel International (MA) Corporation

Report Scope:

In this report, the Global Clinical Trials Support Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trials Support Services Market, By Service:

    Clinical Trial Site Management Patient Recruitment Management Data Management Administrative staff IRB Others

Clinical Trials Support Services Market, By Sponsor:

    Pharmaceutical & Biopharmaceutical Medical Devices Others

Clinical Trials Support Services Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia-Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Clinical Trials Support Services Market.

Available Customizations:

Global Clinical Trials Support Services market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Clinical Trials Support Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Clinical Trial Site Management, Patient Recruitment Management( Patient recruitment & registry services, Patient retention, Others), Data Management, Administrative staff, IRB, Others)
    • 5.2.2. By Sponsor (Pharmaceutical & Biopharmaceutical, Medical Devices, Others)
    • 5.2.3. By Company (2023)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Clinical Trials Support Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Sponsor
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Trials Support Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Sponsor
    • 6.3.2. Mexico Clinical Trials Support Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Sponsor
    • 6.3.3. Canada Clinical Trials Support Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Sponsor

7. Europe Clinical Trials Support Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Sponsor
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Clinical Trials Support Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Sponsor
    • 7.3.2. Germany Clinical Trials Support Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Sponsor
    • 7.3.3. United Kingdom Clinical Trials Support Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Sponsor
    • 7.3.4. Italy Clinical Trials Support Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Sponsor
    • 7.3.5. Spain Clinical Trials Support Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Sponsor

8. Asia-Pacific Clinical Trials Support Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Sponsor
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Clinical Trials Support Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Sponsor
    • 8.3.2. India Clinical Trials Support Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Sponsor
    • 8.3.3. South Korea Clinical Trials Support Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Sponsor
    • 8.3.4. Japan Clinical Trials Support Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Sponsor
    • 8.3.5. Australia Clinical Trials Support Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Sponsor

9. South America Clinical Trials Support Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Sponsor
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Clinical Trials Support Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Sponsor
    • 9.3.2. Argentina Clinical Trials Support Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Sponsor
    • 9.3.3. Colombia Clinical Trials Support Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Sponsor

10. Middle East and Africa Clinical Trials Support Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Sponsor
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Clinical Trials Support Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Sponsor
    • 10.3.2. Saudi Arabia Clinical Trials Support Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Sponsor
    • 10.3.3. UAE Clinical Trials Support Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Sponsor

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Charles River Laboratories International, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Wuxi Apptec
  • 14.3. IQVIA Inc.
  • 14.4. Syneos Health
  • 14.5. Eurofins Scientific
  • 14.6. Ppd, Inc. (Thermo Fisher Scientific Inc.)
  • 14.7. Icon Plc
  • 14.8. Laboratory Corporation Of America Holdings
  • 14.9. Parexel International (MA) Corporation

15. Strategic Recommendations

16. About Us & Disclaimer